Groowe Groowe / Newsroom / OCS
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

OCS News

Oculis Holding AG Ordinary shares

Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses

globenewswire.com
OCS

Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses

globenewswire.com
OCS

Oculis to Participate at the Piper Sandler Virtual Ophthalmology Conference

globenewswire.com
OCS

Oculis to Participate at the Piper Sandler Virtual Ophthalmology Conference

globenewswire.com
OCS

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS

accessnewswire.com
OCS

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS

accessnewswire.com
OCS

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS

accessnewswire.com
OCS

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS

accessnewswire.com
OCS

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS

accessnewswire.com
OCS

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS

prnewswire.com
OCS